KR102380796B1 - Multilamella emulsion type cosmetic composition - Google Patents

Abstract

The present invention relates to a multi-layered lamellar emulsion type cosmetic composition, wherein the multi-layered lamellar emulsion type cosmetic composition of the present invention comprises lipids including ceramides, sterols, fatty acids and fatty alcohols, an emulsifier, an oil, and a calcium source. The multi-layered lamellar emulsion type cosmetic composition according to the present invention provides a skin barrier function for dry and sensitive skin by appropriately supplying calcium ions, or calcium ions and magnesium ions, which play an important role in the proliferation and differentiation of keratinocytes. In addition to strengthening, it is effective in the regeneration and recovery of damaged or aged skin, and in particular, it exhibits excellent effects in relieving itching, moisture barrier, oil and moisture, transepidermal moisture loss, and improving skin soothing effect.

Description

Multi-layered lamellar emulsion type cosmetic composition {MULTILAMELLA EMULSION TYPE COSMETIC COMPOSITION}

The present invention relates to a multi-layered lamellar emulsion type cosmetic composition, and more particularly, a skin barrier function for dry and sensitive skin by appropriately supplying calcium and/or magnesium ions, which play an important role in the proliferation and differentiation of keratinocytes. It relates to a multi-layered lamellar emulsion type cosmetic composition that is effective for strengthening and regenerating damaged or aged skin.

One of the most important functions of the skin is as a barrier that blocks the free movement of various substances such as electrolytes, moisture, allergens, or microorganisms inside and outside the skin, and the stratum corneum performs such a skin barrier function.

The thickness of the stratum corneum is 10~20㎛, and it is responsible for most of the skin barrier function. Among them, keratinocytes synthesize various proteins and lipids and ultimately form the stratum corneum by rapidly changing into corneocytes.

Therefore, the stratum corneum is the final product of the differentiation process in which keratinocytes proliferated from the basal layer of the epidermis come up to the outermost layer, and the intracellular calcium concentration is important in this differentiation. In the upper epidermis at a high concentration, proliferation is inhibited and differentiation occurs. That is, the calcium ion concentration increases from the stratum spinosum, and the calcium ion concentration reaches the highest level in the stratum granulosum to differentiate into the stratum corneum. Therefore, the increase in calcium ions promotes the differentiation of keratinocytes.

The stratum corneum is composed of corneocytes and intercellular lipids, which are described as 'Mortar and Model', and has a protective and protective function from the external environment and a moisturizing function to retain moisture in the skin. It is known that the lamellar structure formed by lipid components between keratinocytes plays an important role in the skin barrier function (Elias PM, Lipid and the epidermal permeability barrier, Arch dermatol Res 1981;27:95-117). , as a result of X-ray diffraction (XRD) and freeze fracture electron microscopy, it is reported that keratinocyte intercellular lipid is a multi-layered lamellar structure existing between keratinocytes (Breathnach AS, Coodman T, Stolinsky C, Cross M. Freeze-fracture replication of stratum corneum of human epidremis. J Anat. 1973; Jan; 114:65-81).

When an abnormality occurs in the skin barrier function due to damage to the stratum corneum, along with dry skin due to excessive evaporation of moisture, the skin becomes itchy and rough, and in severe cases, erythema and inflammation are caused, leading to wrinkles and skin aging.

On the other hand, when emulsifying cosmetics, a self-assembly structure in which energy is minimized is achieved by the interaction between the geometric structure of the constituents constituting the emulsion film formed between the oil phase and the aqueous phase and the various functional groups present in the molecule. These structures include micellar, hexagonal, cubic, lamellar, inverse cubic, inverse hexagonal, inverse micellar ), etc.

Among them, the multi-layered lamellar emulsion formulation containing a physiological lipid mixture including ceramide-based components is an emulsion made in the form of an oil core in the center and a multi-layered lamellar liquid crystal structure surrounding the oil core. , Since this structure is a skin-friendly structure seen in lipid between keratinocytes, it is effective for the skin barrier function and has the advantage of high stability, so the application cases are increasing recently.

Korean Patent Publication No. 10-2000-055082 (published on Sept. 5, 2000) Korean Patent Publication No. 10-0840905 (registered on June 18, 2008) US Patent Application Publication 2010/0286102 (published on November 11, 2010) European Patent Publication EP 1 370 241 (Registered on Nov. 21, 2012) Japanese Patent Publication No. 5432470 (Registered on December 13, 2013) Japanese Laid-Open Patent Publication No. 2014-84308 (published on May 12, 2014) Japanese Laid-Open Patent Publication No. 2016-190816 (published on November 10, 2016) Korean Patent Publication No. 10-2018-0092256 (published on August 17, 2018) Japanese Patent Publication No. 6397527 (Registered on September 7, 2018) Korean Patent Publication No. 10-2009970 (Registered on Aug. 2, 2019)

A first object of the present invention is to provide a multi-layered lamellar emulsion type cosmetic composition having excellent effects of improving itching, moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect.

A second object of the present invention is to strengthen the skin barrier ability of dry and sensitive skin by appropriately supplying calcium and/or magnesium ions, which play an important role in the proliferation and differentiation of keratinocytes, and to regenerate damaged or aged skin. And to provide a multi-layered lamellar emulsion type cosmetic composition effective for recovery.

The general object of the present invention, ceramide, sterol, fatty acid and, a lipid comprising a fatty alcohol; emulsifiers; with oil; calcium gluconate as a calcium source; Magnesium PCA (Magnesium; 2-pyrrolidone-5-carboxylic acid) is included as a magnesium source: 0.01 to 0.5 wt% of calcium gluconate is included based on the total weight of the composition; It can be smoothly achieved by providing a multi-layered lamellar emulsion type cosmetic composition having a skin soothing effect by alleviating itching due to dryness and improving transepidermal moisture loss, in a weight ratio of calcium gluconate: magnesium PCA = 1: 0.6 there is.

delete

delete

delete

delete

delete

delete

The multi-layered lamellar emulsion type cosmetic composition according to the present invention strengthens the skin barrier function of dry and sensitive skin by appropriately supplying calcium ions, or calcium ions and magnesium ions, which play an important role in the proliferation and differentiation of keratinocytes. , it is effective in the regeneration and recovery of damaged or aged skin, and in particular, it exhibits excellent effects in relieving itching, improving moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect.

1 is a view showing the summary of a result report of a clinical trial example.
2 is a photograph of measuring itch relief due to dryness in a clinical test example.
3 is a photograph of the measurement of oil and moisture in a clinical experimental example.
4 is a photograph of measuring the skin soothing effect of a clinical test example.

Hereinafter, the present invention will be described in detail.

The multi-layered lamellar emulsion type cosmetic composition according to the present invention includes lipids including ceramides, sterols, fatty acids and fatty alcohols, an emulsifier, an oil, and a calcium source.

As the ceramide, natural ceramide NS 2, ceramide NP 3, ceramide AS 5, ceramide AP 6, ceramide EOP 9, etc. may be used, and synthetic ceramides such as Pseudoceramide or Ceramide III, or any of these A mixture may be used, and the content thereof is 0.1 to 3% by weight based on the total weight of the composition.

In addition, sterols that contribute to the stabilization of multi-layered lamellar emulsions due to their plate-like structure of fused rings include cholesterol, phytosterol, cholesteryl sulfate, cholesteryl acetate, cholesteryl stearate, cholesteryl isostearate, and cholesteryl hydride. Roxystearate or any mixture thereof may be used, and the content thereof is 0.1 to 3% by weight based on the total weight of the composition.

As the fatty acid, at least one selected from those having 14 to 22 carbon atoms, such as palmitoyl acid, stearic acid, myristic acid, oleic acid, and arachidic acid, is used, and the content thereof is 0.4 to 10% by weight based on the total weight of the composition. am.

In addition, as the fatty alcohol, at least one selected from those having 14 to 22 carbon atoms, such as stearyl alcohol, cetyl alcohol, behenyl alcohol, and cetearyl alcohol, is used, and the content thereof is 0.4 to 10 based on the total weight of the composition. % by weight.

The above-described lipid content is 1 to 20% by weight based on the total weight of the composition, and the total amount of ceramide and sterol is 0.2 to 6% by weight based on the total weight of the composition, and if their content is low, liquid crystal formation and stability may be inferior Conversely, if the content is excessively large, stability degradation and economic feasibility problems may occur due to precipitation due to temperature change.

In addition, as the above-mentioned emulsifier, sorbitan isostearate, PEG-100 stearate, hydrogenated lecithin, polyglyceryl fatty acid ester, polyoxyethylene glyceryl fatty acid ester, alkyl glucoside, polyoxyethylene sorbitan fatty acid ester, or any of these of the mixture is used, and the content is 1 to 20% by weight based on the total weight of the composition.

As the oil, a saturated hydrocarbon-based oil such as squalane, petrolatum, paraffin wax, or the like, or an unsaturated hydrocarbon-based oil of vegetable oil such as camellia oil or sunflower seed oil, or any mixture thereof may be used.

It is preferable to mix and use various types of these oils from the viewpoint of forming a good multi-layered lamellar emulsion and stabilizing other additives, and the content is 2 to 30% by weight based on the total weight of the composition.

On the other hand, calcium gluconate acts as a calcium source, and calcium ions are present in a large amount in the granular layer and promote the differentiation of keratinocytes to finally form the stratum corneum of the skin, strengthening the skin barrier function of dry and sensitive skin, as well as damage And it is an important element helping the regeneration and recovery of aging skin, and the gluconate anion of calcium cluconate serves to promote the transfer of calcium ions to the lower part of the skin layer.

Calcium gluconate is a non-irritating, non-toxic, non-allergenic and safe substance.

The content of calcium gluconate is 0.01 to 1% by weight based on the total weight of the composition, and when it is less than 0.01% by weight, the formation of the stratum corneum is insufficient due to insufficient supply of calcium ions to the skin showing damaged or aged skin barrier function. There is a fear that the functional recovery effect may be reduced, and conversely, if it exceeds 1% by weight, the formation of the stratum corneum may be excessive, causing cosmetic inconvenience.

In addition, the cosmetic composition according to the present invention may further include magnesium PCA (2-pyrrolidone-5-carboxylic acid) as a magnesium source, and the magnesium ions serve as a calcium ion channel inhibitor to regulate the influx of calcium ions into cells. .

When the concentration of magnesium ions is low, calcium ions excessively pass through the channel and increase the differentiation rate of keratinocytes, causing skin keratinization. This allows you to maintain healthy skin.

Magnesium ion-free pyrrolidone carboxylic acid (PCA, 2-pyrrolidone-5-carboxylic acid) is a natural moisturizing factor produced by decomposition of filaggrin, a protein that is attracting attention as one of the major genetic causes of atopic dermatitis. . It shows much better moisturizing power than glycerin or sorbitol, and is a safe substance that does not cause allergies as it is non-irritating and non-toxic.

Magnesium PCA: calcium gluconate = 1: may be added in a weight ratio of 0.5-5, specifically, calcium gluconate: magnesium PCA = 1: 0.6 by weight.

If the content of magnesium PCA is too low, calcium ion control becomes insufficient, causing excessive skin keratinization, and there is a concern that the skin moisturizing effect may be lowered. There are concerns.

In addition, the cosmetic composition according to the present invention may include sphingosine or phytosphingosine, and sphingolipids present in the biological membrane are the main materials constituting the cell membrane together with phospholipids, and the decomposition product of sphingomyelin (SM) is ceramide. (CER), sphingosine (SPH), and sphingosine-1-phosphate (S1P), in particular, S1P is known to affect proliferation and differentiation by moving calcium into the cytoplasm.

The above-described sphingosine or phytosphingosine may be included in an amount of 0.01 to 0.5 parts by weight based on the total weight of the composition.

In addition, as other additives, a moisturizing agent such as sodium hyaluronic acid, glycerin, 1,3-butylene glycol, β-glucan, dipotassium glycyrrhizate, or any mixture thereof, and xanthan gum; An appropriate amount of a thickening agent such as hydroxyethyl cellulose, guar gum, natto gum and the like is included.

In the cosmetic composition according to the present invention, the balance is purified water and is of O/W (Oil in Water) type, and the formulation is lotion, cream, essence, lotion, pack, massage cream, cleansing foam, cleansing water, and the like.

The cosmetic composition according to the present invention is prepared by dissolving and mixing ingredients other than water, fatty alcohol and oil by heating, mixing fatty alcohol and oil, emulsifying while slowly adding to water, and naturally cooling to induce a multi-layered lamellar emulsion do.

The multi-layered lamellar emulsion type cosmetic composition according to the present invention has a high stability because the emulsified particles are formed in a multi-layered lamellar structure, and has a lamellar structure similar to the lipid structure between skin keratinocytes, and contains ceramides, as well as skin It is useful for strengthening the skin barrier by establishing an ionic balance of calcium and magnesium, which is important for menstruation. to be able to maintain

Hereinafter, the present invention will be described in more detail through Examples, Comparative Examples and Experimental Examples.

Examples 1 to 5 and Comparative Examples 1 to 13:

After the cosmetic composition was prepared with the composition components and composition ratios as shown in Tables 1 and 2, the formation of a multi-layered (multi-layer) lamellar liquid crystal structure and the degree of phase stability, moisture barrier improvement, and light weight ratio moisture loss improvement were as follows. was measured, and the results are reported together in Tables 1 and 2.

(A) Formation of a multilayer lamellar liquid crystal structure

By observing the compositions of Examples 1 to 5 and Comparative Examples 1 to 13 with a phase contrast microscopy, it was confirmed that a maltese cross crystal structure, which is a liquid crystal structure of the emulsifier, was generated. That is, when the multilayer lamellar liquid crystal is formed, a Maltesian cross shape appears, and when the multilayer lamellar liquid crystal is not formed, a Maltesian cross shape is not seen.

○: Formation of multi-layered lamellar liquid crystal X: Non-formation of multi-layered lamellar liquid crystal

(B) Stability test

A) Phase stability (45℃)

The compositions of Examples 1 to 5 and Comparative Examples 1 to 13 were stored in a heating chamber at 45° C. for 6 weeks to observe stability.

○: phase stability, X: phase separation

B) Phase stability (-25℃ ~ 20℃)

The compositions of Examples 1 to 5 and Comparative Examples 1 to 13 were cooled / heated in a temperature cycling test chamber of -25 ° C. to 20 ° C. (Cooling/Heating: 1 cycle: 20 ° C. → -25 ° C. → 20 ℃, 4 cycles / 1 day) was stored for 6 weeks to observe the stability.

○: phase stability, X: phase separation

C) Liquid crystal stability (45℃)

The multi-layered lamellar liquid crystal emulsion, which is the composition of Examples 1 to 5 and Comparative Examples 1 to 13, was stored in a heating chamber at 45° C. for 6 weeks to observe stability.

○: Formation of multi-layered lamellar liquid crystal X: Non-formation of multi-layered lamellar liquid crystal

D) Liquid crystal stability (-25℃ ~ 20℃)

The multilayer lamellar liquid crystal emulsion, which is the composition of Examples 1 to 5 and Comparative Examples 1 to 13, was stored for 6 weeks under Cooling/Heating conditions in a Temperature Cycling Test Chamber of -25°C to 20°C to observe stability.

○: Formation of multi-layered lamellar liquid crystal X: Non-formation of multi-layered lamellar liquid crystal

(C) moisture barrier improvement test

First, wash and dry the measurement area, and then rest for 30 min in a closed place with a constant temperature and humidity of 40 to 60% at a room temperature of 20 to 25°C and a humidity of 40 to 60% without movement of air or direct sunlight, and then, Corneometer ^® CM825 (Courage-Khazaka electronic GmbH, Germany) was lightly attached to the skin surface to measure the facial cheek area, which is the measurement site. The measurement unit is expressed in an arbitrary unit (AU) given by the device, and the higher the measurement value, the higher the skin surface moisture content.

The measurement value before application is a measurement value of the skin surface moisture content in the initial skin condition, which is the untreated control group.

After application, the composition of Examples and Comparative Examples was applied once in the morning and in the evening, respectively, and refers to the measurement value of the amount of moisture on the skin surface after 7 days.

Finally, the degree of moisture barrier improvement was expressed as ◎: very good, ○: excellent, □: average, △: no effect.

In this experiment, each experiment was performed 5 times, and the average value was taken.

Skin surface moisture increase (%) = Measured value after 7 days of application / Measured value before application x 100

19 or higher (◎: very good)

14~18 (○: Excellent)

8~13 (□: Normal)

7 or less (△: no effect)

(D) Transepidermal water loss improvement test (TEWL)

Using TEWAMETER TM300 (Courage & Khazaka, Germany), the target site is maintained horizontally and the probe is in contact with the skin of the target area vertically. Trans-epidermal water loss (TEWL) was measured based on “water vapor gradient”.

The measured value was repeated three times in the same area and the average value was taken, and the higher the measured value, the higher the amount of water loss.

The experimental method is to remove the epidermis by performing tape stripping on the skin of the same area 10 times each. The measurement value before application is a measurement value of the skin surface moisture content in the initial, tape-stripped skin state as an untreated control group.

After application, the composition of Examples and Comparative Examples was applied once at an interval of 12 hours, and means a measurement value of the amount of moisture on the skin surface after 72 hours.

Finally, the degree of moisture barrier improvement was expressed as ◎: very good, ○: excellent, □: average, △: no effect.

In this experiment, each experiment was performed 5 times, and the average value was taken.

The degree of improvement in transdermal water loss (TEWL) was expressed as ◎: very good, ○: excellent, □: average, △: bad, and X: very bad.

TEWL improvement (%) = (TEWL measured value after tape stripping - TEWL measured value after 7 days) / TEWL measured value after tape stripping x 100

41 or higher (◎: very good)

21~40 (○: Excellent)

11~20 (□: Normal)

10 or less (△: no effect)

The TEWL improvement rate (%) for Example 4 is shown in Table 3 below.

baseline tape stripping Day 2 Day 3 TEWL, g/m ² /h 7 36 27.5 20.7 TEWL improvement rate (%) - - 23.6 42.5

* Baseline: Transdermal water loss before tape stripping 10 times (TEWL, g/m ² /h)

* Tape stripping: Transdermal water loss immediately after performing tape stripping 10 times (TEWL, g/m ² /h)

Clinical trial example:

The white creamy formulation of Example 4 (Teraset Hydroderm Cream) was provided to the OATC Skin Clinical Test Center to improve itching caused by dryness, moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect on the human body The application test was performed, the result report is cited and described, and the final result report is shown in FIG. 1 .

1. Test purpose

This test was conducted to evaluate the efficacy of the product on the human body for the relief of itching due to dryness, moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect of ‘Theraset Hydroderm Cream’ commissioned by Wizchem.

2. Test product information

1) Test product information

Test product information Test product name Test product control number formulation Theraset Hydroderm Cream 191015-T-85 white cream

2) How to use the test product

Apply twice a day to the face and forearms for 4 weeks.

3. Subject Selection Criteria

Women aged 20 to 60 years old, healthy without any acute or chronic physical diseases including skin diseases, those who could be followed up during the test period, those with red facial skin, and itchy due to dryness were selected.

4. Test method

This human application test was conducted in a constant temperature and humidity space (indoor temperature 20~25℃, humidity 40~60%) of the OATC Skin Clinical Test Center. After washing with the same detergent, the subject rested in a constant temperature and humidity space for 30 minutes , the test was carried out.

(1) Test method

1) Measurement of itch relief due to dryness

In order to confirm the relief of itching due to dryness, after determining whether the skin is dry, the amount of skin moisture and transepidermal water loss were measured, and a questionnaire evaluation of itching caused by dryness was conducted.

To determine whether the skin is dry, the left forearm area was measured before using the test product using Corneometer ^® CM825. For the measurement value, AU (arbitrary units) value, which is an arbitrary unit indicating the moisture content within a certain depth (10-20 μm) below the stratum corneum, was used. If the measurement value is 29 or less, it means that the skin is dry.

For skin moisture measurement, the same left forearm was measured using Epsilon E100 before and after 4 weeks of use of the test product. As the measured value, the ε value representing the average dielectric constant of the skin was used, and as the measured value increases, it means that there is an effect of improving skin moisture.

The amount of transepidermal water loss was measured using Tewameter ^® TM300 on the same left forearm before and after 4 weeks of use of the test product. The measured value was used as a g/m2/h value that measures the degree of water release from the epidermis, and as the measured value decreases, it means that there is an effect of improving the amount of transepidermal water loss.

In order to evaluate the degree of itchiness due to dryness, a subjective evaluation was conducted using a 10-point scale before using the test product and after 4 weeks of use. (1–3 points: unconscious scratching (living, no sleep disturbance), 4–6 points: pruritus to the extent of living, disturbing sleep (not all day), 7–9 points: pruritus interfering with living sleep most of the time , 10 points: severe difficulty in living and sleeping due to itching). The lower the evaluation score, the less itching due to dryness.

2) Moisture barrier measurement

The moisture barrier was measured by measuring the amount of skin moisture and transepidermal moisture loss.

For skin moisture measurement, the same right cheek area was measured using Epsilon E100 before and after 4 weeks of use of the test product. As the measured value, the ε value representing the average dielectric constant of the skin was used, and as the measured value increases, it means that there is an effect of improving skin moisture.

Transepidermal water loss was measured using Tewameter ^® TM300 on the same right cheek area before and 4 weeks after using the test product. The measured value was used as a g/m2/h value that measures the degree of water release from the epidermis, and as the measured value decreases, it means that there is an effect of improving the amount of transepidermal water loss.

3) Measuring oil and moisture

Oil and moisture measurement was performed by measuring skin oil content and skin moisture.

The skin oil content was measured using Sebumeter ^® SM815 on the same right cheek area before and after 4 weeks of use of the test product. As the measurement value, μg/cm 2 value indicating the amount of oil per unit area absorbed in the cassette was used. As the measured value decreases, it means that there is an effect of improving skin oiliness.

For skin moisture measurement, the same right cheek area was measured using Epsilon E100 before and after 4 weeks of use of the test product. As the measured value, the ε value representing the average dielectric constant of the skin was used, and as the measured value increases, it means that there is an effect of improving skin moisture.

4) Measurement of skin soothing effect

To measure the skin soothing effect, the face was taken before and 4 weeks after using the test product using Janus-Ⅲ, and the same right cheek area was measured before and 4 weeks after using the test product using Chromameter CR 400. As the measurement value, a* value indicating the redness of the skin was used. As the measured value decreases, it means that there is a skin soothing effect.

5) Adverse reaction evaluation

At each visit, the examinee visually evaluated whether or not there was an adverse skin reaction at the test site and checked the severity of symptoms. In addition, subjects were instructed to report immediately if they felt an adverse reaction during the test period, even if it was not on the day of the visit. If a skin adverse reaction is reported, the investigator immediately informs the principal investigator, and the principal investigator decides whether to take appropriate measures and participate in the study after confirmation.

(2) Survey evaluation

After using the test product to the subjects, the skin condition was evaluated using a 5-point scale, and the feeling of use was evaluated using either satisfaction or dissatisfaction. Each item was expressed using frequency and percentage.

5. Statistical analysis method

Efficacy analysis of this human application test is for subjects who have completed the test according to the human application test plan (PPA set, Per protocol analysis set).

1) For statistical analysis program, SPSS statistic 25 (SPSS, USA) software was used.

2) Significance was confirmed when the significance probability p <0.05 in the 95% confidence interval.

3) Data were summarized as mean and standard deviation for continuous variables, and frequency and percentage for categorical variables.

4) For statistical analysis, the paired t-test, which is a parametric test, and the Wilcoxon signed rank test, which is a non-parametric test, were used.

6. Test results

(1) Subject information

There were 20 people who completed this human application test, and the sex and age of the subjects are as follows (Table 5).

test subjects 20 people dropout 0 people Final Completion Subject 20 people gender woman 20 people male 0 people Average age (years) 47.35 years old Subject Age 30's 40's 50's 5% 65% 30%

(2) Test measurement results

1) Measurement result of itching relief due to dryness

As a result of confirming the itch relief effect due to dryness after using the test product,

Skin moisture increased statistically significantly ( p <0.001) by 19.92% after 4 weeks of use compared to before product use (Table 6).

A photograph (skin moisture) for measuring itching relief due to dryness is shown in FIG. 2 .

The amount of transepidermal water loss decreased statistically significantly ( p <0.01) by 8.09% after 4 weeks of use compared to before product use (Table 6).

The questionnaire evaluation of itching due to dryness decreased statistically significantly ( p <0.001) by 59.54% after 4 weeks of use compared to before use of the product (Table 6).

Skin moisture measurement result mean ± standard deviation p -value before use 4.00±1.31 - after 4 weeks of use 4.80±1.31 0.000***

p -value: * p <0.05, ** p <0.01, *** p <0.001

Measurement result of transepidermal water loss mean ± standard deviation p -value before use 13.17±3.29 - after 4 weeks of use 12.10±2.17 0.007**

p -value: * p <0.05, ** p <0.01, *** p <0.001

Itching due to dryness questionnaire evaluation result mean ± standard deviation p -value before use 6.55±1.10 - after 4 weeks of use 2.65±0.88 0.000***

p -value: * p <0.05, ** p <0.01, *** p <0.001

2) Moisture barrier measurement result

As a result of confirming the moisture barrier after using the test product, skin moisture increased statistically significantly ( p <0.001) by 10.82% after 4 weeks of use compared to before using the product (Table 9).

The amount of transepidermal water loss decreased statistically significantly ( p <0.05) by 8.44% after 4 weeks of use compared to before product use (Table 10).

Skin moisture measurement result mean ± standard deviation p -value before use 19.81±7.56 - after 4 weeks of use 21.96±7.14 0.000***

p -value: * p <0.05, ** p <0.01, *** p <0.001

Measurement result of transepidermal water loss mean ± standard deviation p -value before use 23.27±6.33 - after 4 weeks of use 21.31±6.25 0.000***

p -value: * p <0.05, ** p <0.01, *** p <0.001

3) Oil and moisture measurement result

As a result of checking the oil and moisture after using the test product, the skin oil content was statistically significantly ( p <0.05) decreased by 16.63% after 4 weeks of use compared to before using the product (Table 11).

Skin moisture increased statistically significantly ( p <0.001) by 10.82% after 4 weeks of use compared to before product use (Table 12 and FIG. 3).

Skin oil measurement result mean ± standard deviation p -value before use 21.65±13.91 - after 4 weeks of use 18.05±12.45 0.049*

p -value: * p <0.05, ** p <0.01, *** p <0.001

Skin moisture measurement result mean ± standard deviation p -value before use 19.81±7.56 - after 4 weeks of use 21.96±7.14 0.000***

p -value: * p <0.05, ** p <0.01, *** p <0.001

4) Measurement result of skin soothing effect

As a result of confirming the skin soothing effect after using the test product, there was a statistically significant (p<0.001) decrease by 5.71% after 4 weeks of use compared to before using the product (Table 13 and FIG. 4).

Measurement result of skin soothing effect mean ± standard deviation p -value before use 14.16±1.86 - after 4 weeks of use 13.36±1.92 0.000***

p-value: *p<0.05, **p<0.01, ***p<0.001

(3) Survey evaluation

As a result of the questionnaire evaluation of the test product conducted on the subjects, the skin condition and feeling of use after using the test product are as follows (Table 14 and Table 15).

Skin condition questionnaire evaluation result question after 4 weeks of use
Frequency (persons) percentage(%)
One 2 3 4 5 One 2 3 4 5 Moisture barrier improvement 0 0 2 17 One 0.0 0.0 10.0 85.0 5.0 improvement of oil and moisture 0 0 2 15 3 0.0 0.0 10.0 75.0 15.0 Improvement of transepidermal water loss 0 0 2 17 One 0.0 0.0 10.0 85.0 5.0 skin soothing effect 0 0 One 16 3 0.0 0.0 5.0 80.0 15.0

※ 1: Very bad, 2: Bad, 3: Average, 4: Good, 5: Very good

User experience survey evaluation result question after 4 weeks of use Frequency (persons) percentage(%) Satisfaction dissatisfaction Satisfaction dissatisfaction skin moisturization 20 0 100.0 0.0 skin softness 20 0 100.0 0.0 product absorbency 19 One 95.0 5.0 Overall satisfaction 20 0 100.0 0.0

8. Conclusions and considerations

1) In this human application test, 20 women aged 20 to 60 years were tested for the improvement of itch relief, moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect of 'Teraset Hydroderm Cream' due to dryness. .

2) As a result of confirming the itch relief effect due to dryness after using the test product, the skin moisture increased by 19.92% statistically significantly ( p <0.001) after 4 weeks of use compared to before using the product, indicating that there is an effect of improving skin moisture. . The amount of transepidermal water loss decreased statistically significantly ( p <0.01) by 8.09% after 4 weeks of use compared to before product use, indicating that there was an effect of improving the amount of transepithelial water loss.

3) As a result of checking the skin moisture barrier after using the test product, the skin moisture increased by 10.82% statistically significantly ( p <0.001) after 4 weeks of use compared to before using the product, indicating that there is an effect of improving skin moisture. The amount of transepidermal water loss decreased statistically significantly ( p <0.05) by 8.44% after 4 weeks of use compared to before product use, indicating that there was an effect of improving the amount of transepithelial water loss.

4) As a result of checking the oil and moisture content after using the test product, the skin oil content decreased by 16.63% statistically significantly ( p <0.05) after 4 weeks of use compared to before using the product, indicating that there is an effect of improving skin oil. Skin moisture increased by 10.82% statistically significantly ( p <0.001) after 4 weeks of use compared to before product use, indicating that there is an effect of improving skin moisture.

5) The questionnaire evaluation of itching due to dryness showed a statistically significant ( p <0.001) decrease by 59.54% after 4 weeks of use compared to before use of the product, indicating that there was an effect of alleviating itching due to dryness.

6) As a result of confirming the skin soothing effect after using the test product, it was statistically significantly ( p <0.001) decreased by 5.71% after 4 weeks of use compared to before using the product, indicating that there is a skin soothing effect.

7) No special skin adverse reactions were observed from the subjects and dermatologists while using the test product during the test period.

8) ‘Theraset Hydroderm Cream’, commissioned by Wizchem Co., Ltd., is judged to be a product that helps to relieve itching caused by dryness after 4 weeks of use, moisture barrier, oil and moisture, transepidermal moisture loss, and skin soothing effect.

Claims (7)

lipids including ceramides, sterols, fatty acids and fatty alcohols; emulsifiers; with oil; calcium gluconate as a calcium source; Magnesium PCA (Magnesium; 2-pyrrolidone-5-carboxylic acid) is included as a magnesium source:
0.01 to 0.5% by weight of the above calcium gluconate is included based on the total weight of the composition;
The above calcium gluconate: magnesium PCA = 1: 0.6 weight ratio,
It has a skin soothing effect by alleviating itching caused by dryness and improving transepidermal moisture loss.
A multi-layered lamellar emulsion type cosmetic composition. delete delete delete delete delete delete

Images